US Stock MarketDetailed Quotes
CLOV Clover Health
- 1.680
- +0.050+3.07%
Close Jul 22 16:00 ET
834.01MMarket Cap-5250P/E (TTM)
1.680High1.580Low3.58MVolume1.650Open1.630Pre Close5.84MTurnover0.91%Turnover RatioLossP/E (Static)496.44MShares1.78052wk High2.85P/B660.80MFloat Cap0.60652wk Low--Dividend TTM393.33MShs Float28.850Historical High--Div YieldTTM6.14%Amplitude0.606Historical Low1.632Avg Price1Lot Size
Clover Health Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 7.74%346.92M | -41.50%2.03B | -43.23%510.25M | -43.74%482.07M | -39.34%513.63M | -63.17%321.99M | 136.19%3.48B | 108.04%898.79M | 100.58%856.82M | 105.27%846.7M |
| Operating revenue | 7.77%341.72M | -42.02%2.01B | -43.90%500.94M | -44.06%477.27M | -39.96%507.87M | -63.68%317.09M | 136.19%3.47B | 107.81%892.86M | 100.14%853.2M | 105.44%845.88M |
| Cost of revenue | -3.50%265.16M | -48.57%1.78B | -49.87%447.99M | -50.11%418.96M | -49.12%436.95M | -68.11%274.79M | 122.67%3.45B | 102.21%893.65M | 92.47%839.8M | 87.30%858.79M |
| Gross profit | 73.21%81.76M | 1,031.88%257.33M | 1,109.99%62.27M | 270.83%63.11M | 734.40%76.67M | 272.94%47.2M | 128.71%22.74M | 152.01%5.15M | 285.75%17.02M | 73.74%-12.09M |
| Operating expense | -16.77%104.11M | 11.57%440M | -2.28%109.92M | 13.33%103.26M | 11.13%100.73M | 24.92%125.09M | -29.30%394.38M | -36.41%112.49M | -34.96%91.11M | -33.27%90.64M |
| Selling and administrative expenses | -18.03%103.79M | -8.61%444.73M | -11.60%109.93M | -13.27%102.31M | -10.77%104.87M | -0.13%126.63M | 9.17%486.64M | 9.00%124.35M | -1.04%117.97M | 9.01%117.53M |
| -General and administrative expense | -18.03%103.79M | -8.61%444.73M | -11.60%109.93M | -13.27%102.31M | -10.77%104.87M | -0.13%126.63M | 9.17%486.64M | 9.00%124.35M | -1.04%117.97M | 9.01%117.53M |
| Depreciation amortization depletion | 13.98%318K | 111.37%2.51M | 180.14%674K | -9.58%557K | 70.48%999K | -66.22%279K | -4.74%1.19M | -199.17%-841K | 413.33%616K | 396.61%586K |
| -Depreciation and amortization | 13.98%318K | 111.37%2.51M | 180.14%674K | -9.58%557K | 70.48%999K | -66.22%279K | -4.74%1.19M | -199.17%-841K | 413.33%616K | 396.61%586K |
| Other operating expenses | ---- | 92.25%-7.24M | 93.80%-683K | 101.43%392K | 81.30%-5.14M | 93.41%-1.81M | -184.32%-93.45M | -117.78%-11.02M | -232.34%-27.48M | -198.48%-27.48M |
| Operating profit | 71.31%-22.35M | 50.85%-182.67M | 55.61%-47.65M | 45.81%-40.16M | 76.58%-24.06M | 10.96%-77.89M | 41.66%-371.65M | 42.53%-107.34M | 50.36%-74.1M | 43.51%-102.73M |
| Net non-operating interest income expense | 99.49%-7K | 0 | 0 | 98.28%-7K | 91.94%-1.36M | 66.26%-139K | 3.05%-413K | 67.02%-408K | ||
| Non-operating interest expense | ---- | -99.49%7K | --0 | --0 | -98.28%7K | ---- | -91.94%1.36M | -66.26%139K | -3.05%413K | -67.02%408K |
| Other net income (expense) | 54.62%-820K | -191.76%-30.69M | -198.12%-22.82M | -33.98%-1.31M | -287.12%-4.75M | -114.58%-1.81M | -49.44%33.44M | 23.26M | -100.85%-980K | 99.09%-1.23M |
| Gain on sale of security | ---467K | -147.56%-4.81M | ---- | ---- | ---- | ---- | -84.71%10.12M | ---70K | -100.85%-980K | 99.09%-1.23M |
| Special income (charges) | 80.46%-353K | -210.93%-25.88M | -177.19%-18.01M | ---1.31M | ---4.75M | ---1.81M | --23.33M | --23.33M | --0 | --0 |
| -Less：Restructuring and merger&acquisition | -80.46%353K | --9.93M | --2.06M | --1.31M | --4.75M | --1.81M | --0 | --0 | --0 | --0 |
| -Less:Impairment of capital assets | ---- | --15.95M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---23.33M | ---- | ---- | ---- |
| Income before tax | 70.93%-23.17M | 37.17%-213.36M | 16.33%-70.47M | 45.07%-41.47M | 72.39%-28.81M | -5.57%-79.7M | 42.23%-339.57M | 55.01%-84.23M | -118.64%-75.49M | 67.14%-104.36M |
| Income tax | ||||||||||
| Net income | 73.60%-19.17M | 37.17%-213.36M | 16.33%-70.47M | 45.07%-41.47M | 72.39%-28.81M | 3.82%-72.61M | 42.23%-339.57M | 55.01%-84.23M | -118.64%-75.49M | 67.14%-104.36M |
| Net income continuous Operations | 70.93%-23.17M | 37.17%-213.36M | 16.33%-70.47M | 45.07%-41.47M | 72.39%-28.81M | -5.57%-79.7M | 42.23%-339.57M | 55.01%-84.23M | -118.64%-75.49M | 67.14%-104.36M |
| Net income discontinuous operations | -43.60%4M | ---- | ---- | ---- | ---- | --7.09M | ---- | ---- | ---- | ---- |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 73.60%-19.17M | 37.17%-213.36M | 16.33%-70.47M | 45.07%-41.47M | 72.39%-28.81M | 3.82%-72.61M | 42.23%-339.57M | 55.01%-84.23M | -118.64%-75.49M | 67.14%-104.36M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 73.60%-19.17M | 37.17%-213.36M | 16.33%-70.47M | 45.07%-41.47M | 72.39%-28.81M | 3.82%-72.61M | 42.23%-339.57M | 55.01%-84.23M | -118.64%-75.49M | 67.14%-104.36M |
| Basic earnings per share | 75.00%-0.04 | 38.03%-0.44 | 16.80%-0.1463 | 43.75%-0.09 | 72.73%-0.06 | 0.00%-0.16 | 50.00%-0.71 | 55.77%-0.1759 | -100.00%-0.16 | 71.79%-0.22 |
| Diluted earnings per share | 75.00%-0.04 | 38.03%-0.44 | 16.80%-0.1463 | 43.75%-0.09 | 72.73%-0.06 | 0.00%-0.16 | 50.00%-0.71 | 55.77%-0.1759 | -100.00%-0.16 | 71.79%-0.22 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg